Araz, M. Et Al. 2024. Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy. Journal of Oncology Pharmacy Practice .

Araz, M., Beypinar, I., Inci, F., KORAL, L., Kocak, M. Z., Korkmaz, M., ... Demirkiran, A.(2024). Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy. Journal of Oncology Pharmacy Practice .

Araz, Murat Et Al. "Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy," Journal of Oncology Pharmacy Practice , 2024

Araz, Murat Et Al. "Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy." Journal of Oncology Pharmacy Practice , 2024

Araz, M. Et Al. (2024) . "Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy." Journal of Oncology Pharmacy Practice .

@article{article, author={Murat Araz Et Al. }, title={Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy}, journal={Journal of Oncology Pharmacy Practice}, year=2024}